JackLeckerman (@JackLeckerman) header
JackLeckerman (@JackLeckerman) profile picture

JackLeckerman organizes global summits, strategic conferences, open forums and professional trainings.

Joined February 2017
Photo by JackLeckerman (@JackLeckerman)Photo by JackLeckerman (@JackLeckerman)Photo by JackLeckerman (@JackLeckerman)Photo by JackLeckerman (@JackLeckerman)Photo by JackLeckerman (@JackLeckerman)Photo by JackLeckerman (@JackLeckerman)Photo by JackLeckerman (@JackLeckerman)Photo by JackLeckerman (@JackLeckerman)Photo by JackLeckerman (@JackLeckerman)Photo by JackLeckerman (@JackLeckerman)
Join the biosimilars community at #BiosimilarsLatAm – Mexico 2026! Two days of regulatory insights, manufacturing innovation, market access discussions and Business Meetings. Members of our Strategic Partners can request an exclusive 10% registration discount.
1
4
Susana Guitar, Chairwoman of #BiosimilarsLatAm – #Mexico2026, join the forum’s 10th Edition! 📅 Nov 18–19 | 📍 Mexico City Two days of industry insights, regulatory discussions, business meetings and networking. Be part of the conversation. Register: jackleckerman.com/events/reg…
2
The right conversation can open a new business opportunity. #BiosimilarsLatAm – #Mexico2026 is designed to bring pharmaceutical decision-makers, manufacturers, regulators and industry partners into the same conversation.
1
4
Beyond the conference sessions, pre-scheduled 20-minute business meetings offer a structured way to connect with relevant professionals and explore potential collaborations. Make the connections that move the industry forward. 🔗 jackleckerman.com/events/reg… #StrategicPartnerships
1
How can continuous improvement enhance particulate control in pre-fillable syringes for biosimilars? #BiosimilarsLatAm, Philippe Lauwers, Terumo Pharmaceutical Solutions, case study demonstrating how a holistic approach to manufacturing quality can deliver measurable results.
1
29
“Kaizen in Action: A Holistic Approach to Particulate Reduction in Pre-fillable Syringes (PFSs) for Biosimilars,” Philippe will explore how Terumo Pharmaceutical Solutions addressed visible particulate contamination in ready-to-use polymer syringes through continuous improvement.
4
25
📍 Join us on November 18–19, 2026, at Camino Real Polanco, Mexico City, to explore manufacturing innovation, quality and the evolving biosimilars landscape across Latin America. 🔗 jackleckerman.com/events/reg… #TerumoPharmaceuticalSolutionsDivision #DrugDelivery #PatientExperience
9
As a sponsor of Biosimilars LatAm – Mexico 2026, Terumo Medical Care Solutions brings expertise in innovative medical devices, injectable drug delivery solutions and integrated CDMO services, including sterile fill-finish in polymer pre-fillable syringes and glass vials.
23
This case study highlights how robust manufacturing processes and effective contamination-control strategies can help meet the stringent quality requirements of ophthalmic drugs, where the use of prefilled syringes continues to grow.
2
The approach combined enhanced cleaning practices, low-particulate materials, static electricity management, operator training and analytical method optimization. 📉 The result: a 97% reduction in visible particulate levels over 18 months.
4
How can analytical comparability accelerate biosimilar development? #BiosimilarsLatAm #Mexico2026, Kathya Rashida of Cuba’s CIM will present its experience with 2C12, a pembrolizumab biosimilar candidate. 🤝 #CIM is a Sponsor. 📅 Nov 18–19 | Mexico City
1
71
Este foro reúne a líderes de la industria farmacéutica, fabricantes, autoridades regulatorias y otros actores clave para analizar los cambios que están configurando el mercado de los biosimilares en #latam. jackleckerman.com/events/age… #BiosimilarsLatAm #Mexico2026 #Biosimilars
13
How could evolving evidence on interchangeability and switching help shape biosimilar development? Join ANVISA 🇧🇷 , ANMAT 🇦🇷 and CECMED 🇨🇺 perspectives at #BiosimilarsLatAm - #Mexico2026, Nov 18–19. 🔗 Download the agenda: jackleckerman.com/events/age…
33
🔬 @Cytiva as a Sponsor of #BiosimilarsLatAm #Mexico2026 A global biotechnology leader and part of Danaher, Cytiva supports the development and manufacture of next-generation therapeutics. 📅 Nov 18–19 | Mexico City 🔗 jackleckerman.com/events/reg… #Biosimilars #Biotechnology
25
One region, multiple pathways. How can biosimilar companies navigate registration across LATAM? Explore harmonization, reliance and regulatory convergence with #COFEPRIS, #ANMAT & #PAHO / #WHO at #BiosimilarsLatAm Mexico 2026. 📅 Nov 18–19 🔗 Agenda jackleckerman.com/events/age…
24
🔬 Meet Sonia Mayra Pérez Tapia, General Director at UDIBI, speaking at #BiosimilarsLatAm #Mexico2026! 🤝 UDIBI is a COFEPRIS-authorized laboratory specializing in pharmaceutical analytics and biosimilarity assessment. 🔗 jackleckerman.com/events/reg…
26
Meet Susana Guitar, Chairwoman of #BiosimilarsLatAm – #Mexico2026. With leaders from COFEPRIS, PAHO/WHO, ANMAT, ANVISA & CECMED, we'll explore REGULATION • MANUFACTURING • MARKET ACCESS 🤝 Business Meetings + Expert Consulting + 10th Edition Celebration jackleckerman.com/events/reg…
19
#BiosimilarsLatAmMexico2026, Peter Gurske, Seafront Biotech, opportunities emerging from closer MERCOSUR–EU cooperation & the role of European suppliers in supporting the region’s biopharma. Connect, exchange perspectives, explore new opportunities for the LatAm bioindustry.
1
12